Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 2/2012

01-03-2012 | Original Paper

General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia

Authors: János M. Réthelyi, Pál Czobor, Patrícia Polgár, Beatrix Mersich, Sára Bálint, Éva Jekkel, Krisztina Magyar, Ágnes Mészáros, Ágnes Fábián, István Bitter

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 2/2012

Login to get access

Abstract

Earlier studies suggested more severe overall cognitive impairments in deficit versus non-deficit schizophrenia; however, the specific contribution of different cognitive domains to this overall cognitive impairment remains unclear. The purpose of this study was to compare the two subtypes in general cognitive functioning as well as in individual cognitive domains using the composite score approach. One hundred and forty-three patients fulfilling the criteria for the deficit syndrome were compared with 123 patients diagnosed with non-deficit schizophrenia. Neurocognitive functioning was assessed by a neuropsychological test battery measuring the domains of sustained vigilance/attention, working memory, short-term memory, verbal memory, cognitive flexibility, and ideation fluency. Using the raw neuropsychological measures, we calculated a global index of cognitive impairment and domain-specific composite z-scores. Association between these composite scores and the deficit syndrome was examined by logistic regression analysis. After adjusting for relevant covariates including sex, age, education, smoking, and antipsychotic dose, results indicated a significant increase in the likelihood of deficit syndrome as a function of global (OR = 5.40; 95% CI 3.02–9.65) as well as domain-specific impairments (OR > 2 for all individual domains except for short-term memory). Cognitive flexibility was an independent predictor (OR = 2.92; 95% CI 1.47–5.80), whereas other cognitive domains demonstrated no unique contribution to the general cognitive impairment. Patients with deficit schizophrenia suffer from a more severe degree of neurocognitive impairment, which is qualitatively similar to the dysfunction seen in non-deficit schizophrenia. However, our results indicate that cognitive flexibility is specifically impaired in deficit versus non-deficit patients and may therefore represent a core feature of this subtype.
Literature
1.
go back to reference Carpenter WT Jr, Heinrichs DW, Wagman AM (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578–583PubMed Carpenter WT Jr, Heinrichs DW, Wagman AM (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578–583PubMed
2.
go back to reference Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr (2001) A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 58:165–171PubMedCrossRef Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr (2001) A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 58:165–171PubMedCrossRef
3.
go back to reference Galderisi S, Maj M (2009) Deficit schizophrenia: an overview of clinical, biological and treatment aspects. Eur Psychiatry 24:493–500PubMedCrossRef Galderisi S, Maj M (2009) Deficit schizophrenia: an overview of clinical, biological and treatment aspects. Eur Psychiatry 24:493–500PubMedCrossRef
4.
go back to reference Green MF (2007) Stimulating the development of drug treatments to improve cognition in schizophrenia. Annu Rev Clin Psychol 3:159–180PubMedCrossRef Green MF (2007) Stimulating the development of drug treatments to improve cognition in schizophrenia. Annu Rev Clin Psychol 3:159–180PubMedCrossRef
5.
go back to reference Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT Jr (1994) Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry 51:804–811PubMedCrossRef Buchanan RW, Strauss ME, Kirkpatrick B, Holstein C, Breier A, Carpenter WT Jr (1994) Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Arch Gen Psychiatry 51:804–811PubMedCrossRef
6.
go back to reference Bryson G, Whelahan HA, Bell M (2001) Memory and executive function impairments in deficit syndrome schizophrenia. Psychiatry Res 102:29–37PubMedCrossRef Bryson G, Whelahan HA, Bell M (2001) Memory and executive function impairments in deficit syndrome schizophrenia. Psychiatry Res 102:29–37PubMedCrossRef
7.
go back to reference Brazo P, Marie RM, Halbecq I, Benali K, Segard L, Delamillieure P, Langlois-Thery S, Van Der Elst A, Thibaut F, Petit M, Dollfus S (2002) Cognitive patterns in subtypes of schizophrenia. Eur Psychiatry 17:155–162PubMedCrossRef Brazo P, Marie RM, Halbecq I, Benali K, Segard L, Delamillieure P, Langlois-Thery S, Van Der Elst A, Thibaut F, Petit M, Dollfus S (2002) Cognitive patterns in subtypes of schizophrenia. Eur Psychiatry 17:155–162PubMedCrossRef
8.
go back to reference Galderisi S, Maj M, Mucci A, Cassano GB, Invernizzi G, Rossi A, Vita A, Dell’Osso L, Daneluzzo E, Pini S (2002) Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. Am J Psychiatry 159:983–990PubMedCrossRef Galderisi S, Maj M, Mucci A, Cassano GB, Invernizzi G, Rossi A, Vita A, Dell’Osso L, Daneluzzo E, Pini S (2002) Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. Am J Psychiatry 159:983–990PubMedCrossRef
9.
go back to reference Cohen AS, Saperstein AM, Gold JM, Kirkpatrick B, Carpenter WT Jr, Buchanan RW (2007) Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr Bull 33:1201–1212PubMedCrossRef Cohen AS, Saperstein AM, Gold JM, Kirkpatrick B, Carpenter WT Jr, Buchanan RW (2007) Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophr Bull 33:1201–1212PubMedCrossRef
10.
go back to reference Jaeger J, Czobor P, Berns SM (2003) Basic neuropsychological dimensions in schizophrenia. Schizophr Res 65:105–116PubMedCrossRef Jaeger J, Czobor P, Berns SM (2003) Basic neuropsychological dimensions in schizophrenia. Schizophr Res 65:105–116PubMedCrossRef
11.
go back to reference Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA (2002) Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159:1018–1028PubMedCrossRef Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA (2002) Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159:1018–1028PubMedCrossRef
12.
go back to reference Psychiatric American Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association Press, Washington, DC Psychiatric American Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association Press, Washington, DC
13.
go back to reference Rethelyi JM, Bakker SC, Polgar P, Czobor P, Strengman E, Pasztor PI, Kahn RS, Bitter I (2010) Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Am J Med Genet B Neuropsychiatr Genet 153B:792–801PubMed Rethelyi JM, Bakker SC, Polgar P, Czobor P, Strengman E, Pasztor PI, Kahn RS, Bitter I (2010) Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Am J Med Genet B Neuropsychiatr Genet 153B:792–801PubMed
14.
go back to reference Balázs J, Bitter I, Hideg K, Vitrai J (1998) The Hungarian version of the M.I.N.I. and the M.I.N.I. Plus (in Hungarian). Psychiatria Hungarica 13:160–168 Balázs J, Bitter I, Hideg K, Vitrai J (1998) The Hungarian version of the M.I.N.I. and the M.I.N.I. Plus (in Hungarian). Psychiatria Hungarica 13:160–168
15.
go back to reference Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMed Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276PubMed
16.
go back to reference Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30:119–123PubMedCrossRef Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT Jr (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30:119–123PubMedCrossRef
17.
go back to reference Baldessarini RJ, Tarazi FI (2001) Drugs and the treatment of psychiatric disorders: antipsychotic and antimaniac agents. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 485–520 Baldessarini RJ, Tarazi FI (2001) Drugs and the treatment of psychiatric disorders: antipsychotic and antimaniac agents. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman’s the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 485–520
18.
go back to reference Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667PubMedCrossRef Woods SW (2003) Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663–667PubMedCrossRef
19.
go back to reference Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests. Administration, norms, and commentary. Oxford University Press, Oxford Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests. Administration, norms, and commentary. Oxford University Press, Oxford
20.
go back to reference Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale, NJ Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale, NJ
21.
go back to reference Owens SF, Rijsdijk F, Picchioni MM, Stahl D, Nenadic I, Murray RM, Toulopoulou T (2011) Genetic overlap between schizophrenia and selective components of executive function. Schizophr Res 127:181–187PubMedCrossRef Owens SF, Rijsdijk F, Picchioni MM, Stahl D, Nenadic I, Murray RM, Toulopoulou T (2011) Genetic overlap between schizophrenia and selective components of executive function. Schizophr Res 127:181–187PubMedCrossRef
22.
go back to reference Cascella NG, Testa SM, Meyer SM, Rao VA, Diaz-Asper CM, Pearlson GD, Schretlen DJ (2008) Neuropsychological impairment in deficit vs. non-deficit schizophrenia. J Psychiatr Res 42:930–937PubMedCrossRef Cascella NG, Testa SM, Meyer SM, Rao VA, Diaz-Asper CM, Pearlson GD, Schretlen DJ (2008) Neuropsychological impairment in deficit vs. non-deficit schizophrenia. J Psychiatr Res 42:930–937PubMedCrossRef
23.
go back to reference Wang X, Yao S, Kirkpatrick B, Shi C, Yi J (2008) Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin. Psychiatry Res 158:195–205PubMedCrossRef Wang X, Yao S, Kirkpatrick B, Shi C, Yi J (2008) Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin. Psychiatry Res 158:195–205PubMedCrossRef
24.
go back to reference Polgar P, Farkas M, Nagy O, Kelemen O, Rethelyi J, Bitter I, Myers CE, Gluck MA, Keri S (2008) How to find the way out from four rooms? The learning of “chaining” associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia. Schizophr Res 99:200–207PubMedCrossRef Polgar P, Farkas M, Nagy O, Kelemen O, Rethelyi J, Bitter I, Myers CE, Gluck MA, Keri S (2008) How to find the way out from four rooms? The learning of “chaining” associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia. Schizophr Res 99:200–207PubMedCrossRef
25.
go back to reference Szendi I, Racsmany M, Cimmer C, Csifcsak G, Kovacs ZA, Szekeres G, Galsi G, Toth F, Nagy A, Garab EA, Boda K, Gulyas G, Kiss JG, Dombi J, Pleh C, Janka Z (2010) Two subgroups of schizophrenia identified by systematic cognitive neuropsychiatric mapping. Eur Arch Psychiatry Clin Neurosci 260:257–266PubMedCrossRef Szendi I, Racsmany M, Cimmer C, Csifcsak G, Kovacs ZA, Szekeres G, Galsi G, Toth F, Nagy A, Garab EA, Boda K, Gulyas G, Kiss JG, Dombi J, Pleh C, Janka Z (2010) Two subgroups of schizophrenia identified by systematic cognitive neuropsychiatric mapping. Eur Arch Psychiatry Clin Neurosci 260:257–266PubMedCrossRef
26.
go back to reference Dickinson D, Ragland JD, Gold JM, Gur RC (2008) General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol Psychiatry 64:823–827PubMedCrossRef Dickinson D, Ragland JD, Gold JM, Gur RC (2008) General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol Psychiatry 64:823–827PubMedCrossRef
27.
go back to reference Tuulio-Henriksson A, Perala J, Saarni SI, Isometsa E, Koskinen S, Lonnqvist J, Suvisaari J (2011) Cognitive functioning in severe psychiatric disorders: a general population study. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-010-0186-y Tuulio-Henriksson A, Perala J, Saarni SI, Isometsa E, Koskinen S, Lonnqvist J, Suvisaari J (2011) Cognitive functioning in severe psychiatric disorders: a general population study. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-010-0186-y
28.
go back to reference Cascella NG, Fieldstone SC, Rao VA, Pearlson GD, Sawa A, Schretlen DJ (2010) Gray-matter abnormalities in deficit schizophrenia. Schizophr Res 120:63–70PubMedCrossRef Cascella NG, Fieldstone SC, Rao VA, Pearlson GD, Sawa A, Schretlen DJ (2010) Gray-matter abnormalities in deficit schizophrenia. Schizophr Res 120:63–70PubMedCrossRef
29.
go back to reference Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62:649–659PubMedCrossRef Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62:649–659PubMedCrossRef
30.
go back to reference Segarra R, Zabala A, Eguiluz JI, Ojeda N, Elizagarate E, Sanchez P, Ballesteros J, Gutierrez M (2010) Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-010-0146-6 Segarra R, Zabala A, Eguiluz JI, Ojeda N, Elizagarate E, Sanchez P, Ballesteros J, Gutierrez M (2010) Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-010-0146-6
31.
go back to reference Hori H, Noguchi H, Hashimoto R, Nakabayashi T, Omori M, Takahashi S, Tsukue R, Anami K, Hirabayashi N, Harada S, Saitoh O, Iwase M, Kajimoto O, Takeda M, Okabe S, Kunugi H (2006) Antipsychotic medication and cognitive function in schizophrenia. Schizophr Res 86:138–146PubMedCrossRef Hori H, Noguchi H, Hashimoto R, Nakabayashi T, Omori M, Takahashi S, Tsukue R, Anami K, Hirabayashi N, Harada S, Saitoh O, Iwase M, Kajimoto O, Takeda M, Okabe S, Kunugi H (2006) Antipsychotic medication and cognitive function in schizophrenia. Schizophr Res 86:138–146PubMedCrossRef
32.
go back to reference Elie D, Poirier M, Chianetta J, Durand M, Gregoire C, Grignon S (2010) Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder. J Psychopharmacol 24:1037–1044PubMedCrossRef Elie D, Poirier M, Chianetta J, Durand M, Gregoire C, Grignon S (2010) Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder. J Psychopharmacol 24:1037–1044PubMedCrossRef
33.
go back to reference Malaspina D, Coleman E (2003) Olfaction and social drive in schizophrenia. Arch Gen Psychiatry 60:578–584PubMedCrossRef Malaspina D, Coleman E (2003) Olfaction and social drive in schizophrenia. Arch Gen Psychiatry 60:578–584PubMedCrossRef
34.
go back to reference Horan WP, Blanchard JJ (2003) Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia. Schizophr Res 65:125–137PubMedCrossRef Horan WP, Blanchard JJ (2003) Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia. Schizophr Res 65:125–137PubMedCrossRef
35.
go back to reference Milev P, Ho BC, Arndt S, Andreasen NC (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162:495–506PubMedCrossRef Milev P, Ho BC, Arndt S, Andreasen NC (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162:495–506PubMedCrossRef
36.
go back to reference Ojeda N, Pena J, Sanchez P, Elizagarate E, Ezcurra J (2008) Processing speed mediates the relationship between verbal memory, verbal fluency, and functional outcome in chronic schizophrenia. Schizophr Res 101:225–233PubMedCrossRef Ojeda N, Pena J, Sanchez P, Elizagarate E, Ezcurra J (2008) Processing speed mediates the relationship between verbal memory, verbal fluency, and functional outcome in chronic schizophrenia. Schizophr Res 101:225–233PubMedCrossRef
37.
go back to reference Sanchez P, Ojeda N, Pena J, Elizagarate E, Yoller AB, Gutierrez M, Ezcurra J (2009) Predictors of longitudinal changes in schizophrenia: the role of processing speed. J Clin Psychiatry 70:888–896PubMedCrossRef Sanchez P, Ojeda N, Pena J, Elizagarate E, Yoller AB, Gutierrez M, Ezcurra J (2009) Predictors of longitudinal changes in schizophrenia: the role of processing speed. J Clin Psychiatry 70:888–896PubMedCrossRef
38.
go back to reference Bell M, Tsang HW, Greig TC, Bryson GJ (2009) Neurocognition, social cognition, perceived social discomfort, and vocational outcomes in schizophrenia. Schizophr Bull 35:738–747PubMedCrossRef Bell M, Tsang HW, Greig TC, Bryson GJ (2009) Neurocognition, social cognition, perceived social discomfort, and vocational outcomes in schizophrenia. Schizophr Bull 35:738–747PubMedCrossRef
39.
go back to reference McDowd J, Tang TC, Tsai PC, Wang SY, Su CY (2011) The association between verbal memory, processing speed, negative symptoms and functional capacity in schizophrenia. Psychiatry Res 187:329–334PubMedCrossRef McDowd J, Tang TC, Tsai PC, Wang SY, Su CY (2011) The association between verbal memory, processing speed, negative symptoms and functional capacity in schizophrenia. Psychiatry Res 187:329–334PubMedCrossRef
40.
go back to reference Moller HJ, Jager M, Riedel M, Obermeier M, Strauss A, Bottlender R (2010) The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci 260:367–384PubMedCrossRef Moller HJ, Jager M, Riedel M, Obermeier M, Strauss A, Bottlender R (2010) The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci 260:367–384PubMedCrossRef
41.
go back to reference Strauss GP, Harrow M, Grossman LS, Rosen C (2010) Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr Bull 36:788–799PubMedCrossRef Strauss GP, Harrow M, Grossman LS, Rosen C (2010) Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr Bull 36:788–799PubMedCrossRef
42.
go back to reference Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R (2004) Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry 61:866–876PubMedCrossRef Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R (2004) Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry 61:866–876PubMedCrossRef
43.
go back to reference Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS (2010) Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 67:674–682PubMedCrossRef Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS (2010) Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 67:674–682PubMedCrossRef
44.
go back to reference Fisher M, Holland C, Merzenich MM, Vinogradov S (2009) Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry 166:805–811PubMedCrossRef Fisher M, Holland C, Merzenich MM, Vinogradov S (2009) Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry 166:805–811PubMedCrossRef
Metadata
Title
General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia
Authors
János M. Réthelyi
Pál Czobor
Patrícia Polgár
Beatrix Mersich
Sára Bálint
Éva Jekkel
Krisztina Magyar
Ágnes Mészáros
Ágnes Fábián
István Bitter
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 2/2012
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-011-0224-4

Other articles of this Issue 2/2012

European Archives of Psychiatry and Clinical Neuroscience 2/2012 Go to the issue